Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 542650 | NSE Symbol : METROPOLIS | ISIN : INE112L01020 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
04-Dec-2024	09-Dec-2024	Preferential Issue	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2024 ,inter alia, to consider and approve issuance of equity shares of the Company on a preferential basis and Postal ballot notice. Acquisition of the 100% stake in Core Diagnostics Private Limited, India, ('Core Diagnostics') from its existing shareholder, Core Diagnostics (Mauritius) Private Limited for a total purchase consideration of INR 246.83 crores to be discharged partly by cash and partly by way of preferential issue and allotment of equity shares of the Company Preferential Issue (As per BSE Announcement Dated on 09/12/2024)
30-Oct-2024	08-Nov-2024	Quarterly Results	Quarterly Results Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2024 (As per BSE Announcement Dated on 08/11/2024)
05-Aug-2024	10-Aug-2024	Quarterly Results	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2024 Financial Results for the quarter ended June 30, 2024 (As Per BSE Announcement Dated on: 10/08/2024)
14-May-2024	21-May-2024	Quarterly Results	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2024 Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2024 Outcome of Board Meeting (As Per BSE Announcement Dated on 21/05/2024)
26-Jan-2024	02-Feb-2024	Quarterly Results	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023. Please find attached herewith, Unaudited Financial Results (Standalone & Consolidated) For quarter and nine months ended December 31, 2023. Please find attached herewith, Outcome of Board meeting held today i.e friday, January 01, 2024 (As per BSE Announcement Dated on 02/02/2024)
29-Oct-2023	04-Nov-2023	Quarterly Results	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Saturday November 04 2023 to inter alia Consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and half year ended September 30 2023. Consider and approve the declaration of Interim Dividend for the Financial Year 2023-24 if any. METROPOLIS HEALTHCARE LIMITED has informed BSE about Board Meeting to be held on 04 Nov 2023 to consider financial statements for the period ended September 2023. Financial results / Dividend. This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the record date. Please find attached herewith, outcome of the Board Meeting held today i.e Saturday, 4th November, 2023 This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved and declared payment of an Interim dividend at the rate of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the Record Date. Please find attached herewith the financial results for the quarter and half year ended September 30, 2023. This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the record date. (As Per BSE Announcement Dated on 04.11.2023) This is to inform you that the Company on Sunday, November 05 has published an extract of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2023 as approved by the Board of Directors of the Company in their Meeting held on Saturday, November 04, 2023. Please find enclosed , the copy published in Free Press Journal (English) and Navshakti (Marathi). (As Per BSE Announcement Dated on 05.11.2023)
26-Jul-2023	02-Aug-2023	Quarterly Results	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 ,inter alia, to consider and approve We wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 02, 2023, to inter alia, Consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2023; Further, we also wish to inform you that in terms of the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company has been closed for the Designated Persons of the Company and their immediate relatives with effect from July 01, 2023 and shall re-open 48 hours after the declaration of the Financial Results of the Company for the quarter ended June 30, 2023, as intimated to the stock exchanges vide its letter MHL/Sec&Legal/2023-24/25 dated June 29, 2023. Please find attached herewith, Unaudited Financial results (standalone and consolidated) for quarter ended June 30, 2023 This is to inform you that, the Board of Directors of the Company in their meeting held today i.e August 02, 2023, have inter alia approved few agendas, details of which are enclosed herewith. (As per BSE Announcement Dated on 02/08/2023)
20-Jun-2023	19-Jun-2023	Change in Other Executives	This is to inform you that the Board of Directors of the Company at their Meeting held on Monday, June 19, 2023 have approved the appointment of Ms. Neha Shah as Interim Company Secretary & Key Managerial Personnel of the Company w.e.f. June 20,2023. Ms. Neha will continue to act as Interim Compliance officer of the Company approved by the Board in its Meeting held on December 09, 2022 (Ref No: MHL/Sec&Legal/2022-23/77) In terms of Regulation 30(5) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Key Managerial Personnel's ('KMP') of the Company have been authorized severally for the purpose of determining materiality of an event or information and making disclosure of the same to the Stock Exchange(s). Accordingly, Ms. Neha Shah, Interim Company Secretary & Compliance Officer of the Company has also been authorized under the aforesaid regulation.
09-May-2023	16-May-2023	Accounts	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 inter alia to consider and approve We wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 16 2023 to inter alia consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2023. Further we also wish to inform you that in terms of the Companys Code of Fair Disclosure of Unpublished Price Sensitive Information the Trading Window for dealing in the securities of the Company has been closed for the Designated Persons of the Company and their immediate relatives with effect from April 01 2023 and shall reopen 48 hours after the declaration of the Financial Results of the Company for the quarter and financial year ended March 31 2023 as intimated to the stock exchanges vide its letter MHL/Sec&Legal/2022-23/98 dated March 30 2023. In continuation to our letter Ref: MHL/Sec&Legal/2023-24/13 dated May 16, 2023, it is further informed that as per the requirement of Circular No. LIST/COMP/74/2018-19 dated June 20, 2018 w.r.t. Enforcement of SEBI orders regarding Appointment of Directors by Listed Companies, we hereby affirm that Mr. Sanjay Bhatnagar (DIN: 00867848) and Mr. Vivek Gambhir (DIN: 06527810) who were re-appointed as Non-Executive Independent Directors by the Board in its Meeting held on May 16, 2023 for a second term of 5 years, subject to the approval of Shareholders, are not debarred from holding the office as Director by virtue of any SEBI order or any other such authority. You are requested to kindly take the same on record. (As Per BSE Announcement dated on 17.05.2023)
01-Apr-2023	31-Mar-2023	Others	This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. Friday, March 31, 2023, have approved reconstitution of Audit Committee and Risk Management Committee of the Company with effect from April 01, 2023
03-Feb-2023	10-Feb-2023	Quarterly Results	Intimation of Notice of Board Meeting scheduled to be held on Friday, February 10, 2023 This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. Friday, February 10, 2023 have inter-alia: i. Approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022 and noted the Limited Review Report The Copy of the Unaudited Standalone & Consolidated Financial Results of the Company as approved by the Board of Directors together with the Limited Review Report thereon for the quarter and nine months ended December 31, 2022 is enclosed herewith as Annexure - 1. ii. Approved and Declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight Only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two Only) per Equity Share for the Financial Year 2022-23. The Board has fixed Thursday, February 23, 2023, as the 'Record Date'. The Interim Dividend will be paid to the shareholders within 30 days of declaration. This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. Friday, February 10, 2023 have inter-alia: i. Approved and Declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight Only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two Only) per Equity Share for the Financial Year 2022-23. The Board has fixed Thursday, February 23, 2023, as the 'Record Date' for the purpose of ascertaining eligibility of the shareholders for payment of Interim Dividend. The Interim Dividend will be paid to the shareholders within 30 days of declaration. (As Per BSE Announcement dated on 10.02.2023) This is to inform you that the Board of Directors at its Meeting held on Friday, February 10, 2023 has inter alia, considered and approved the amendments in the Code of Fair Disclosure of Unpublished Price Sensitive Information Policy ('Code of Fair Disclosure') of the Company. The said Code of Fair Disclosure is enclosed herewith and is also being hosted on the website of the Company, viz. www.metropolisindia.com (As Per BSE Announcement Dated on 11.02.2023)
09-Dec-2022	09-Dec-2022	Change in Other Executives	This is to inform you that based on the recommendation of the Nomination & Remuneration Committee, the Board of Directors of the Company in their Meeting held today i.e. Friday, December 09, 2022, have inter-alia: Approved the appointment of Mr. Surendran Chemmenkotil as Chief Executive Officer ('CEO') of the Company w.e.f. January 02, 2023; 2. Accepted and took on record the resignation of Ms. Simmi Singh Bisht from the post of Company Secretary and Compliance Officer of the Company (Designated as Head - Legal and Secretarial) w.e.f. January 07, 2023; 3. Approved the appointment of Ms. Neha Shah, Associate Company Secretary (Membership No. ACS 51465) as an Interim Compliance Officer of the Company w.e.f. January 08, 2023.
31-Oct-2022	08-Nov-2022	Quarterly Results	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2022 inter alia to consider and approve We wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday November 08 2022 to inter alia consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022. Further we wish to inform you that in terms of the Companys Code of Fair Disclosure of Unpublished Price Sensitive Information the Trading Window for dealing in the securities of the Company has been closed for Designated Persons of the Company and/or their immediate relatives with effect from October 01 2022 and shall re-open 48 hours after declaration of Financial Results of the Company for the quarter and half year ended September 30 2022. Board of Directors at their Meeting held today i.e. Tuesday, November 08, 2022, based on recommendation of the Audit Committee, have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022 and noted the Limited Review Report issued by the Statutory Auditors of the Company thereon. The copy of Unaudited Standalone & Consolidated Financial Results of the Company as approved by the Board of Directors together with the Limited Review Report thereon for the quarter and half year ended September 30, 2022 enclosed herewith. (As Per BSE Announcement Dated on 08.11.2022) This is to inform you that the Company on Thursday, November 10, 2022, had published the extract of the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022 as approved by the Board of Directors in their meeting held on Tuesday, November 08, 2022. Please find enclosed, the copy published in Free Press Journal (English) and Navshakti (Marathi). Kindly take the same on record. (As per BSE Announcement Dated on 10/11/2022)
04-Aug-2022	10-Aug-2022	Quarterly Results	Quarterly Results Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 10, 2022, inter alia: To consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2022. (As Per BSE Announcement dated on 03.08.2022) Dear Sir/ Madam, This is to inform you that the Board of Directors at their Meeting held today i.e. Wednesday, August 10, 2022 have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022 and took note of the Limited Review Report issued by the Statutory Auditors of the Company thereon. The copy of Unaudited Standalone & Consolidated Financial Results of the Company as approved by the Board of Directors together with the Limited Review Report thereon for the quarter ended June 30, 2022 are enclosed as Annexure - 1. The meeting commenced at 02:00 pm and concluded at 04.25 pm. (As Per BSE Announcement dated on 10.08.2022)
12-Jul-2022	18-Jul-2022	Accounts	Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2022 inter alia to consider and approve the revised Audited Standalone Financial results of the Company for the Quarter and Year ended March 312022 after taking on record the amalgamation of the 8(Eight) wholly owned Subsidiary Companies with the Company. Metropolis Healthcare Limited has informed the Exchange about Board Meeting held on 18-Jul-2022 to approve Revised Audited Standalone Financial Results of the Company along with revised Audit Report thereon for the quarter and year ended March 31, 2022. (Post-Merger), on account of Merger Order issued by NCLT, Mumbai as submitted by the Company earlier via letter no. MHL/Sec&Legal/2022-23/30 approving the scheme of Amalgamation & Arrangement of Merger by Absorption of subsidiaries with the Company (As per BSE Announcement Dated on 18/07/2022) This is to inform the Exchange that the Board of Directors in their Meeting held on 18-Jul-2022 has approved amendments to ''Metropolis-Restrictive Stock Unit Plan, 2020'' (the 'MHL-RSU Plan 2020'), subject to shareholders' approval in ensuring 22nd Annual General Meeting (As Per BSE Announcement dated on 19.07.2022)

1 2

LOGIN HERE

Metropolis Healthcare Ltd

Board Meeting